Works for your patients.
Works for you.

Explore the technology, clinical evidence, and adaptive intelligence behind iLet Bionic Pancreas.

Intelligence that adapts.

From everyday fluctuations to changing insulin needs over time, the adaptive intelligence behind iLet continuously learns, adapts and keeps up with the individual.

iLet learns from change

iLet learns from glucose patterns and insulin responses every five minutes, refining personalized dosing for basal, corrections, and meals over time.

Continuous adaptation with no manual optimization

Learns and adapts dosing decisions as individual needs evolve, reducing manual adjustments and patient-initiated corrections.

Makes room for more patient-centered care

Dosing adapts between visits, your clinical judgment and expertise guide the care.

Life changes. Insulin needs change. iLet keeps up with life.

Proven outcomes.
Intelligence that adapts.

Backed by 3 years of real world data.

For starting HbA1c from

<7% to >14%1

See real world outcomes for a broader population

HbA1c → GMI Reduction

1.6%1

HbA1c to GMI reduced by an average of 1.6%

Time in Range (70–180 mg/dL)

+25%1

Improvement in continuous glycemic time-in-range, offering patients consistent protection day and night.

Time <54 mg/dL of time

0.27%1

ADA Goal: <1% of time

See the Evidence

Ask more of AID. Less of your patients.

iLet takes on more of the decisions behind insulin dosing giving patients more freedom from the calculations, settings and dosing decisions that can make diabetes management feel like constant work.

No diabetes math

Patients don't have to make dosing decisions, iLet dynamically adapts without the need for correction factors or insulin to carb ratios.

Read More

No traditional basal programming

iLet continuously determines insulin needs and adapts over time to match the individual's changing physiology-without relying on patient programmed basal rates.

Read More

No exact carb counting

Patients simply characterize meals as Usual for me, More or Less, rather than calculating exact carbohydrate amounts, while iLet continuously learns and adapts meal doses over time.

Read More

No patient-initiated correction doses

Advanced Intelligence determines when additional insulin is needed and delivers the dose autonomously

Read More

Freedom to focus on the person. Guided by your expertise.

Adaptive Intelligence takes on more of the dosing decisions so your expertise can shift from programming therapy settings to selecting, supporting, and caring for the person.

A young person wearing an iLet pump prepares food in the kitchen with a caregiver nearby

Clinical judgment remains central

Identify appropriate patients, evaluate outcomes and tailor care to individual needs.

More meaningful patient conversations

Explore patient goals, daily routines and challenges to support whole-person care.

Insights that inform clinical decisions

Use Bionic Reports to assess glucose patterns, insulin delivery and patient interactions to guide care.

Adaptive dosing between visits

Rely on iLet to continuously learn and adapt insulin dosing as patient needs evolve, while maintaining clinical oversight.

The most connected AID.

iLet integrates with compatible continuous glucose monitoring systems to support automated insulin delivery.

  • Dexcom G7

    Dexcom G7

    Dexcom CGM Systems bring trusted CGM technology together with the iLet Bionic Pancreas for a simple, connected AID experience. Dexcom G7 supports users ages 2+, while Dexcom G7 15 Day offers adults 18+ up to 15 days of wear, plus a 12-hour grace period~.

  • FreeStyle Libre 3+

    FreeStyle Libre 3+

    FreeStyle Libre 3 Plus sensor is the world’s smallest2 15-day CGM sensor for all ages (2+)3, with glucose readings sent automatically every minute to iLet. Together, FreeStyle Libre 3 Plus sensor and iLet create one easy*, single-app experience.

  • Eversense 365

    Eversense 365

    Eversense 365 is the world’s only one-year CGM, delivering exceptional accuracy, including industry-leading accuracy in the low glucose range.4 Together, Eversense 365 and the iLet Bionic Pancreas bring year-long CGM convenience to a simple, connected insulin delivery experience.

It's time to rethink who could benefit from AID.

From patients who need help reaching their goals to those achieving them with significant daily effort, consider who could benefit from an AID system that continuously adapts to life.

Newly diagnosed

Help newly diagnosed patients reach their glycemic goals with much less mental burden from the start.

Not meeting goals on current therapy

Whether on MDI or pump therapy who are not at goal.

At goal and working hard to stay there

Working hard, feeling burnt out from relentless diabetes decision making.

Your next iLet patient may already be doing well.
They may just be doing too much.

Find Your Next iLet Patient

Real people. Real stories. Real change.5
Hear why people love it.

Angela, age 48

"Within 1 week of using iLet Bionic Pancreas, my time in range went from 46% to 82%, and my A1C went from 8.2 to 6.1-I’m in awe!"

Cruz, age 16

"I’m always on the go, so it’s awesome not having to worry about counting carbs. iLet Bionic Pancreas figured me out in only a few days and honestly just takes care of me now. My A1C’s 5.7, and I hardly do anything."

Faith, mom of Piper, age 10

“Piper has her life back. She now has the freedom and independence to be a kid again. And as her parents, it’s given us peace. My kid is safe and healthy. That is everything.”

From prescription to patient training, we've got you covered.

From prescription through training and ongoing support, Beta Bionics helps your practice and patients get started with iLet.

A young person wearing an iLet pump prepares food in the kitchen with a caregiver nearby

Identify & Prescribe

Identify an appropriate patient and submit the iLet prescription via Parachute, Online Referral or Fax.

We'll help navigate access

Beta Bionics support helps patients and practices navigate coverage, fulfillment and the steps required to move toward start.

Get the patient started

Patients receive training and support on meal announcements, system interaction.

We're there beyond day one

Clinical and patient resources help reinforce successful iLet use after initiation.

Less to program from the start.

Easy to initiate. No basal rates. No correction factors. No insulin-to-carb ratios to build.
Just set glycemic target and enter patient body weight to initiate.

Prescribe iLet
Person holding the iLet device

Who is your next iLet patient?

Consider the patients in your practice who could benefit from proven glycemic outcomes with less reliance on dosing math, traditional therapy settings and constant dosing decisions